ES2224256T3 - Disolucion solida de un agente antifungico con biodisponibilidad mejorada. - Google Patents

Disolucion solida de un agente antifungico con biodisponibilidad mejorada.

Info

Publication number
ES2224256T3
ES2224256T3 ES97931119T ES97931119T ES2224256T3 ES 2224256 T3 ES2224256 T3 ES 2224256T3 ES 97931119 T ES97931119 T ES 97931119T ES 97931119 T ES97931119 T ES 97931119T ES 2224256 T3 ES2224256 T3 ES 2224256T3
Authority
ES
Spain
Prior art keywords
weight
composition
compound
polymer
solid solution
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES97931119T
Other languages
English (en)
Spanish (es)
Inventor
Surendra A. Sangekar
Ping I. Lee
Winston A. Vadino
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck Sharp & Dohme LLC
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Application granted granted Critical
Publication of ES2224256T3 publication Critical patent/ES2224256T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Plural Heterocyclic Compounds (AREA)
ES97931119T 1996-06-28 1997-06-25 Disolucion solida de un agente antifungico con biodisponibilidad mejorada. Expired - Lifetime ES2224256T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US67270696A 1996-06-28 1996-06-28
US672706 1996-06-28

Publications (1)

Publication Number Publication Date
ES2224256T3 true ES2224256T3 (es) 2005-03-01

Family

ID=24699673

Family Applications (1)

Application Number Title Priority Date Filing Date
ES97931119T Expired - Lifetime ES2224256T3 (es) 1996-06-28 1997-06-25 Disolucion solida de un agente antifungico con biodisponibilidad mejorada.

Country Status (7)

Country Link
EP (1) EP0954288B1 (enExample)
JP (1) JP2000514057A (enExample)
AT (1) ATE273002T1 (enExample)
AU (1) AU3483497A (enExample)
DE (1) DE69730241T2 (enExample)
ES (1) ES2224256T3 (enExample)
WO (1) WO1998000113A1 (enExample)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6524832B1 (en) 1994-02-04 2003-02-25 Arch Development Corporation DNA damaging agents in combination with tyrosine kinase inhibitors
US6632455B2 (en) 1997-12-22 2003-10-14 Schering Corporation Molecular dispersion composition with enhanced bioavailability
NZ504834A (en) * 1997-12-22 2001-12-21 Schering Corp Tricyclic amide molecular dispersion composition with enhanced bioavailability
US6350786B1 (en) * 1998-09-22 2002-02-26 Hoffmann-La Roche Inc. Stable complexes of poorly soluble compounds in ionic polymers
US6316462B1 (en) 1999-04-09 2001-11-13 Schering Corporation Methods of inducing cancer cell death and tumor regression
JP5159012B2 (ja) 1999-12-23 2013-03-06 メイン・ファ−マ・インタ−ナショナル・プロプライエタリ−・リミテッド 不良溶解性の薬物に対する改良された医薬組成物
GB0019296D0 (en) * 2000-08-07 2000-09-27 Nipa Lab Limited Treatment for part processed leather
ITMI20022748A1 (it) 2002-12-23 2004-06-24 Eurand Int Dispersioni solide stabilizzate di farmaco in un carrier organico e procedimento per la loro preparazione.
ITMI20032020A1 (it) 2003-10-17 2005-04-18 Italfarmaco Spa Nuovi agenti antifungini azolici con diminuita interazione con i citocromi metabolici
JP2010526848A (ja) * 2007-05-11 2010-08-05 エフ．ホフマン−ラ ロシュ アーゲー 難溶性薬物用の医薬組成物
JP2015531749A (ja) 2012-06-21 2015-11-05 メイン ファーマ インターナショナル プロプライエタリー リミテッドＭａｙｎｅ Ｐｈａｒｍａ Ｉｎｔｅｒｎａｔｉｏｎａｌ Ｐｔｙ．Ｌｔｄ． イトラコナゾール組成物及び投与剤形、並びにその使用方法
WO2016198983A1 (en) 2015-06-09 2016-12-15 Bend Research Inc. Formulations to achieve rapid dissolution of drug from spray-dried dispersions in capsules
US11058682B2 (en) 2015-08-08 2021-07-13 Alfred E. Tiefenbacher (Gmbh & Co. Kg) Gastro-resistant formulation containing posaconazole
EP3925601B1 (en) 2016-02-26 2024-07-17 Alfred E. Tiefenbacher (GmbH & Co. KG) Gastro-resistant formulation containing posaconazole and a polymeric precipitation inhibitor
TR201620462A2 (tr) 2016-12-31 2018-07-23 Abdi Ibrahim Ilac Sanayi Ve Ticaret Anonim Sirketi POSAKONAZOL İÇEREN FARMASÖTİK BİLEŞİMLER ve ÜRETİM YÖNTEMİ
US10702520B1 (en) 2019-01-29 2020-07-07 Slayback Pharma Llc Pharmaceutical compositions of posaconazole
EP4196096A1 (en) 2020-08-13 2023-06-21 Alfred E. Tiefenbacher (GmbH & Co. KG) Gastro-resistant high-strength formulation containing posaconazole
EP4091604B1 (en) 2021-11-25 2024-04-03 Alfred E. Tiefenbacher (GmbH & Co. KG) Granules containing posaconazole
WO2023012378A1 (en) 2021-11-25 2023-02-09 Alfred E. Tiefenbacher (Gmbh Und Co. Kg) Granules containing posaconazole

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SG43179A1 (en) * 1991-12-18 1997-10-17 Warner Lambert Co A process for the prepatation of a solid dispersion
DK0736030T3 (da) * 1993-12-21 2001-10-29 Schering Corp Fungicide tetrahydrofuraner

Also Published As

Publication number Publication date
WO1998000113A1 (en) 1998-01-08
DE69730241D1 (de) 2004-09-16
EP0954288B1 (en) 2004-08-11
EP0954288A1 (en) 1999-11-10
JP2000514057A (ja) 2000-10-24
AU3483497A (en) 1998-01-21
DE69730241T2 (de) 2005-08-11
ATE273002T1 (de) 2004-08-15

Similar Documents

Publication Publication Date Title
US5972381A (en) Solid solution of an antifungal agent with enhanced bioavailability
ES2310164T3 (es) Dispositivo de liberacion controlada por la matriz.
US20230226063A1 (en) Pharmaceutical formulation of palbociclib and a preparation method thereof
ES2951547T3 (es) Composiciones farmacéuticas que comprenden nilotinib
US4673564A (en) Sustained release pharmaceutical composition of solid medical material
ES2224002T3 (es) Formulaciones farmaceuticas que contienen darifenacina.
ES2645008T3 (es) Formas de dosificación sólida de bendamustina
JP5777170B2 (ja) 速溶性固体剤形
EP0954288B1 (en) Solid solution of an antifungal agent with enhanced bioavailability
US6531158B1 (en) Drug delivery system for enhanced bioavailability of hydrophobic active ingredients
JPH05112445A (ja) 作用開始を速くし潜在特性を増加させる移送システム
EP3307246B1 (en) Formulations to achieve rapid dissolution of drug from spray-dried dispersions in capsules
SK104895A3 (en) Pharmaceutical composition and its use
US20070264332A1 (en) Sustained Release Pharmaceutical Formulation
JP2010059212A (ja) バイオアベイラビリティーを高めた分子分散組成物
ES2471076T3 (es) Compuestos de inclusión de silodoxina-ciclodextrina
ES2288117B1 (es) Composicion farmaceutica solida de gabapentina.
EP0200252B1 (en) Tablets comprising trimethoprim and a sulfonamide
CA2258679C (en) Solid solution of an antifungal agent with enhanced bioavailability
JPH01168619A (ja) 新規な酢酸クロルマジノン固形製剤
JPH07291869A (ja) 経口投与用製剤
MXPA01005274A (en) Compositions comprising cefuroxime axetil